MycoBiomDB – Record Details (MyCo_3441)

Biomarker Record Details

Database ID: MyCo_3441
DB IDMyCo_3441
TitleIncreased peripheral blood TCD4+ counts and serum SP-D levels in patients with chronic paracoccidioidomycosis, during and after antifungal therapy
Year2017
PMID29091134
Fungal Diseases involvedParacoccidioidomycosis
Associated Medical ConditionNone
GenusParacoccidioides
Speciesbrasiliensis
OrganismParacoccidioides brasiliensis
Ethical StatementThe study was approved by the local ethics committee (#283/2009-CEP). All the patients were informed of the purpose of the study, and written informed consent was obtained from all the participants.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameTCD4+
Biomarker Full NameTCD4+
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationBrazil
CohortEighty-seven PCM patients from the Tropical Diseases Ward and the Systemic Mycoses Outpatient Clinic of the University Hospital, Botucatu Medical School, São Paulo State University, were studied. Patients in whom the clinical manifestations were compatible with PCM were considered as either confirmed cases or probable cases.
Cohort No.87
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismParacoccidioidomycosis (PCM) is a systemic and granulomatous mycosis caused by thermally dimorphic fungi of the genus Paracoccidioides, and is characterised by antigen-dependent immunosup- pression. Incidences of PCM are con- fined to Latin America, and are especially prevalent in Brazil, Colombia, and Venezuela, predominantly among rural workers (Shikanai-Yasuda et al. 2006). The active disease presents as two main clinical forms - the acute/ subacute form (AF) and the chronic form (CF). Patients with the AF are typically children, teenagers, and young adults; they present a history of a short duration (two months in median length) and exhibit clinical manifes-tations characterised by the involvement of organs, such as the lymph nodes, bone marrow, liver, and spleen.
TechniqueAnalytic
Analysis MethodFlow Cytometry Analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedFlow Cytometry Analysis
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone